Both constructs were subjected to DNA sequencing to confirm that mutations had not been introduced during PCR amplification. The recombinant plasmids were propagated in Escherichia coli prior to recovery and electroporation (9) into S. aureus RN4220 (1) . Transformants were grown overnight at 37°C with aeration in Iso-Sensitest broth, diluted 1:50 in fresh medium, and allowed to grow for 60 min. Anhydrotetracycline (250 ng/ml) was added to cultures to induce expression from the xyl/tetO promoter on pAJ96, and incubation was continued for 3 h. The cultures were then subjected to novobiocin susceptibility testing by agar dilution in Iso-Sensitest agar. After 24 h of incubation at 37°C, MICs were determined as the lowest concentration of novobiocin that prevented visible colony growth (11) .
Expression of gyrB from S. saprophyticus in S. aureus RN4220 conferred a ca. 64-fold increase in resistance to novobiocin, relative to wild-type RN4220/SH1000 and RN4220 carrying unmodified pAJ96 (Table 1 ). This increase in resistance was not the result of elevated gene dosage of the drug target, since expression of gyrB from S. aureus SH1000 in RN4220 did not affect novobiocin susceptibility (Table 1) . Since the level of novobiocin resistance achieved following expression of S. saprophyticus gyrB in S. aureus in trans was essentially the same as observed for wildtype S. saprophyticus (Table 1 ), it appears that the intrinsic novobiocin resistance of this organism results predominantly from expression of a novobiocin-resistant GyrB protein.
To identify amino acid residues in S. saprophyticus GyrB with a role in novobiocin resistance, we aligned the amino acid sequences of GyrB from S. aureus and S. saprophyticus and compared these with previously published data on novobiocin resistance polymorphisms selected in S. aureus (2) (Fig. 1) . Residues G 85 and K 140 of S. saprophyticus GyrB were predicted to contribute to novobiocin resistance, since mutations at corresponding sites in S. aureus GyrB (D 89 G, R 144 G, R 144 I, or R 144 S) are associated with acquired resistance to novobiocin (2) , and the amino acids differ at these positions in the two species (Fig. 1) . To examine the role of these residues in novobiocin resistance, sitedirected mutagenesis was used to replace these amino acids with those found at the corresponding locations in S. aureus GyrB. The QuikChange kit (Stratagene, Amsterdam, The Netherlands) was used in conjunction with gel-purified oligonucleotide primers (G 85 D forward, 5Ј-GATAATGGCCGTGGTATACCTGTTGA TATTCAAGAAAAAATGGGACGTCC; G 85 D reverse, 5Ј-GG ACGTCCCATTTTTTCTTGAATATCAACAGGTATACCAC GGCCATTATC; K 140 R forward, 5Ј-GAAGATCTTGAAGTAT ACGTGTATAGAGACCGCAAAGTTTATCATCAAGG; K 140 R reverse, 5Ј-CCTTGATGATAAACTTTGCGGTCTC TATACACGTATACTTCAAGATCTTC [site-directed mutations are underlined]) using pAJ96-SAP as a PCR template to generate constructs pAJ96-SAP85, pAJ96-SAP140, and pAJ96-SAP85/140, encoding the substitutions G 85 D , K 140 R, and both G 85 D and K 140 R, respectively. Introduction of the G 85 D mutation into S. saprophyticus GyrB reduced the novobiocin MIC against RN4220 carrying the corresponding gene from 8 g/ml to 1 g/ml ( Table 1) . Mutation of the S. saprophyticus gyrB gene to encode R 140 conferred a fourfold decrease in novobiocin resistance (Table  1) . When both G 85 D and K 140 R mutations were introduced into S. saprophyticus GyrB, novobiocin resistance in RN4220 fell to a level equivalent to that encoded by the novobiocinsensitive S. aureus enzyme.
In conclusion, our results show that the GyrB subunit of DNA gyrase is important in the innate resistance of S. saprophyticus to novobiocin and that G 85 and K 140 of GyrB are critical for the expression of resistance. 
